REG - RUA Life Sciences - Director/PDMR Shareholding

Rua Life SciencesAnnouncement

14/12/2022 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221214:nRSN7234Ja&default-theme=true

RNS Number : 7234J  RUA Life Sciences PLC  14 December 2022

14 December 2022

 

 

RUA Life Sciences Plc

 

("RUA Life Sciences", the "Company" or the "Group")

Director Dealing

 

RUA Life Sciences, the holding company of a group of medical device businesses
focused on the exploitation of the patented long-term implantable biostable
polymer, Elast-Eon(TM), announces that it was notified on 14 December 2022
that Lachlan Smith, Chief Financial Officer, purchased 19,341 ordinary shares
in the Company at 54.2p on 14 December 2022.

 

Following the purchase, Lachlan Smith owns 19,341 ordinary shares of the
Company.

 

For further information contact:

 

RUA Life Sciences

Bill Brown,
Chairman
           Tel: +44 (0)1294 317073

Caroline Stretton, Group Managing
Director
              Tel: +44 (0)1294 317073

 

Cenkos Securities plc  (Nominated Adviser and Broker)
Tel: +44 (0)20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)

Michael Johnson (Sales)

 

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated

 a)  Name:                                                         Lachlan Smith via SIPP
 2.  Reason for the notification

 a)  Position/status:                                              Chief Financial Officer

 b)  Initial notification/Amendment:                               Initial notification

 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor

 a)  Name:                                                         RUA Life Sciences plc
 b)  LEI:                                                          213800BMVB22PVOJ9Z28
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 a)  Description of the financial instrument, type of instrument:  Ordinary Shares of 5 pence

     Identification code:                                          GB0033360586
 b)  Nature of the transaction:                                    Purchase of Ordinary Shares

 c)  Price(s) and volume(s):                                       Price(s)  Volume(s)

                                                                   54.17p    19,341
 d)  Aggregated information:

     · Aggregated volume:                                          n/a

     · Price:
 e)  Date of the transaction:                                      14 December 2022

 f)  Place of the transaction:                                     London Stock Exchange

d)

Aggregated information:

· Aggregated volume:

· Price:

 

n/a

e)

Date of the transaction:

14 December 2022

 

f)

Place of the transaction:

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFFDFDLEESESE